This Week at FDA: Makary and a CRL for KalVista, more FDA staff leaving, advisory panels slowed by staff cuts

This Week at FDAThis Week at FDABiologics/ biosimilars/ vaccinesCDERLeadershipMedical DevicesPharmaceuticalsRegulatory Intelligence/PolicyUnited StatesUS Food and Drug Administration (FDA)